- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
| Image | Product Name | API Name | Last Drug Patent Expires | Details | Year of start producing |
|---|---|---|---|---|---|
 | CAS No. 1207947-49-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1227917-63-6, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | CAS No. 1207853-23-3, Ritlecitinib Intermediate | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif) | Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | 5/5/2041 (Ruxolitinib); 3/14/2034 (Tofacitinib); 12/3/2034 (Ritlecitinib); 11/30/2032 (Baricitinib); 2/19/2034 (Abrocitinib) | View detail » | 2016 |
